BRIEF-Genevant Sciences And Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

Reuters05:20

BRIEF-Genevant Sciences And <a href="https://laohu8.com/S/ABUS">Arbutus Biopharma</a> Announce $2.25 Billion Global Settlement With <a href="https://laohu8.com/S/MRNA">Moderna</a>

March 3 (Reuters) - Arbutus Biopharma Corp ABUS.O:

GENEVANT SCIENCES AND ARBUTUS BIOPHARMA ANNOUNCE $2.25 BILLION GLOBAL SETTLEMENT WITH MODERNA
ROIVANT SCIENCES - ARBUTUS IS CURRENTLY EVALUATING A RETURN OF CAPITAL TO SHAREHOLDERS FOR Q3 OF CALENDAR YEAR 2026

Source text: ID:nGNX7ZNTnK

Further company coverage: ABUS.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616374698?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 05:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616374698","market":"nz","top_or_hot":-1,"title":"BRIEF-Genevant Sciences And Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Genevant Sciences And <a href=\"https://laohu8.com/S/ABUS\">Arbutus Biopharma</a> Announce $2.25 Billion Global Settlement With <a href=\"https://laohu8.com/S/MRNA\">Moderna</a></title></head><body><p><span>March 3 (Reuters)</span><span> - </span>Arbutus Biopharma Corp <span>ABUS.O</span>:</p><ul><li><p>GENEVANT SCIENCES AND ARBUTUS BIOPHARMA ANNOUNCE $2.25 BILLION GLOBAL SETTLEMENT WITH MODERNA</p></li><li><p>ROIVANT SCIENCES - ARBUTUS IS CURRENTLY EVALUATING A RETURN OF CAPITAL TO SHAREHOLDERS FOR Q3 OF CALENDAR YEAR 2026</p></li></ul><p>Source text: <span>ID:nGNX7ZNTnK</span></p><p>Further company coverage: <span>ABUS.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Genevant Sciences And Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Genevant Sciences And Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-04 05:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Genevant Sciences And <a href=\"https://laohu8.com/S/ABUS\">Arbutus Biopharma</a> Announce $2.25 Billion Global Settlement With <a href=\"https://laohu8.com/S/MRNA\">Moderna</a></title></head><body><p><span>March 3 (Reuters)</span><span> - </span>Arbutus Biopharma Corp <span>ABUS.O</span>:</p><ul><li><p>GENEVANT SCIENCES AND ARBUTUS BIOPHARMA ANNOUNCE $2.25 BILLION GLOBAL SETTLEMENT WITH MODERNA</p></li><li><p>ROIVANT SCIENCES - ARBUTUS IS CURRENTLY EVALUATING A RETURN OF CAPITAL TO SHAREHOLDERS FOR Q3 OF CALENDAR YEAR 2026</p></li></ul><p>Source text: <span>ID:nGNX7ZNTnK</span></p><p>Further company coverage: <span>ABUS.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABUS","symbol_name":"Arbutus Biopharma Corporation","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA7RZBMP:1","article_id":"2616374698","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616374698","pubTimestamp":1772572836,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Genevant Sciences And Arbutus Biopharma Announce $2.25 Billion Global Settlement With ModernaMarch 3 (Reuters) - Arbutus Biopharma Corp ABUS.O:GENEVANT SCIENCES AND ARBUTUS BIOPHARMA ANNOUNCE $2","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ABUS":"Arbutus Biopharma Corporation","ROIV":"Roivant Sciences Ltd.","BK4007":"制药","BK4139":"生物科技"},"translate_title":"简介-Genevant Sciences和Arbutus Biopharma宣布与Moderna达成22.5亿美元的全球和解","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABUS":0.9,"ROIV":0.9},"content_text":"BRIEF-Genevant Sciences And Arbutus Biopharma Announce $2.25 Billion Global Settlement With ModernaMarch 3 (Reuters) - Arbutus Biopharma Corp ABUS.O:GENEVANT SCIENCES AND ARBUTUS BIOPHARMA ANNOUNCE $2.25 BILLION GLOBAL SETTLEMENT WITH MODERNAROIVANT SCIENCES - ARBUTUS IS CURRENTLY EVALUATING A RETURN OF CAPITAL TO SHAREHOLDERS FOR Q3 OF CALENDAR YEAR 2026Source text: ID:nGNX7ZNTnKFurther company coverage: ABUS.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616374698","isCrawlerRequest":true}